TABLE 1.
Demographics and clinical characteristics of patients enrolled in the Development of Interstitial Lung Disease (ILD) in Patients with SARS-CoV-2 infection (CovILD) study
| Subjects | 145 |
| Age years | 57±14 |
| Female | 63 (43) |
| BMI kg·m−2 | 26±5 |
| Smoking history | 57 (39) |
| Current smokers | 4 (3) |
| Pack-years | 8±16 |
| Comorbidities | |
| None | 33 (23) |
| Cardiovascular disease | 58 (40) |
| Hypertension | 44 (30) |
| Pulmonary disease | 27 (19) |
| COPD | 8 (6) |
| Asthma | 10 (7) |
| ILD# | 1 (1) |
| Metabolic disease | 63 (43) |
| Hypercholesterolaemia | 27 (19) |
| Diabetes mellitus, type 2 | 24 (17) |
| Chronic kidney disease | 10 (7) |
| Chronic liver disease | 8 (6) |
| Malignancy | 17 (12) |
| Immunodeficiency¶ | 9 (6) |
| Hospitalised | 109 (75) |
| In-hospital treatment+ | |
| Oxygen supply | 72 (66) |
| Noninvasive ventilation | 3 (3) |
| Invasive ventilation | 29 (27) |
Data are presented as n, mean±sd or n (%). BMI: body mass index. #: n=1 with a history of radiation-induced pneumonitis; ¶: due to disease or ongoing immunosuppressive treatment: renal transplantation (n=1), psoriasis vulgaris (n=1), morbus Hashimoto (n=1), leukaemia (n=1), lymphoma (n=1), gout (n=1), polyarthritis (n=1). +: all patients needing noninvasive or invasive ventilation were supplied with oxygen before intensive care unit admission; relative numbers depict the treatment of in-hospital patients.